Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 19, 2013
Aesica, the global contract manufacturing organisation (CMO), and EmulTech, jointly announce the commercial development of ET4ME - an innovative emulsion technology for product formulation.
read more
Friday, February 15, 2013
Aesica, the global contract manufacturing organisation (CMO), announces that it will be joining Britest in a collaboration where members share knowledge and risk in defining innovative solutions to key manufacturing challenges.
read more
Friday, February 15, 2013
Metrics Inc. has added a new formulation scientist to its growing staff of pharmaceutical chemists.
read more
Wednesday, February 13, 2013
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of a Supplemental New Drug ...
read more
Monday, February 11, 2013
Ash Stevens Inc. (ASI), a full service contract pharmaceutical manufacturer, is in the final stages of completing a multi-year, multi-million dollar expansion to its cGMP manufacturing facility in Riverview, Michigan. All construction on the project ...
read more
Thursday, February 07, 2013
Metrics Inc. has appointed Joseph E. “Joe” Cobb Jr., CPIP, as director of pharmaceutical development.
read more
Tuesday, February 05, 2013
Pharmatek, a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has purchased another Xcelodose® 600S system. This acquisition doubles the company's manufacturing production rate for ...
read more
Friday, February 01, 2013
Metrics Inc. has appointed Joe Cascone as senior director of operations.
In his new role at Metrics, Cascone will manage the company’s commercial drug product manufacturing and packaging capabilities. He also is responsible for facility-related ...
read more
Wednesday, January 30, 2013
Leading events organiser, UBM Live, announced today that CPhI Southeast Asia, the first in its annual portfolio of global pharmaceutical ingredients events for 2013, will return this March 20-22 to the Jakarta International Expo in Indonesia. With ...
read more
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has appointed James Fife as the company’s senior director of parenteral operations for its manufacturing facility in ...
read more
Wednesday, January 23, 2013
CAMO Software, leaders in multivariate data analysis solutions, today announced the release of a new version of the Unscrambler® X Process Pulse software for process monitoring. The software is designed to be used by laboratory staff, technical ...
read more
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, today announced the award of a US$3.3 million contract from the US Defense Threat Reduction Agency (DTRA) to develop biodefence vaccine adjuvants using the company’s ...
read more
Thursday, January 17, 2013
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry today announced that Kristin Arnold, Ph.D. has joined the company as vice president, product development ...
read more
Thursday, January 17, 2013
Amgen today announced plans to build a new manufacturing facility in the Tuas Biomedical Park area of Singapore. Over the next several years, Amgen anticipates investing approximately $200 million to build an innovative new facility, which will ...
read more
Tuesday, January 15, 2013
Biotest Pharmaceuticals Corp. (BPC), a wholly owned U.S. subsidiary of Biotest AG (Dreieich, Germany), today announced it has entered into a strategic long-term manufacturing, supply, and license agreement with ADMA Biologics,Inc.(ADMA).
read more